Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
20.10
+0.39 (1.98%)
At close: Nov 22, 2024, 4:00 PM
19.65
-0.45 (-2.23%)
After-hours: Nov 22, 2024, 4:53 PM EST
Monopar Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 2.88 | 3.23 | 2.95 | 2.63 | 2.44 | 2.36 | |
| Research & Development | 4.12 | 5.6 | 7.59 | 6.49 | 4.07 | 1.97 | |
| Operating Expenses | 7 | 8.83 | 10.54 | 9.13 | 6.51 | 4.32 | |
| Operating Income | -7 | -8.83 | -10.54 | -9.13 | -6.51 | -4.32 | |
| Interest & Investment Income | 0.35 | 0.43 | 0.02 | 0.02 | 0.08 | 0.1 | |
| EBT Excluding Unusual Items | -6.47 | -8.4 | -10.52 | -9.1 | -6.43 | -4.22 | |
| Other Unusual Items | - | - | - | - | 0.12 | - | |
| Pretax Income | -6.47 | -8.4 | -10.52 | -9.1 | -6.3 | -4.22 | |
| Net Income | -6.47 | -8.4 | -10.52 | -9.1 | -6.3 | -4.22 | |
| Net Income to Common | -6.47 | -8.4 | -10.52 | -9.1 | -6.3 | -4.22 | |
| Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 2 | 2 | |
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 2 | 2 | |
| Shares Change (YoY) | 23.15% | 8.69% | 1.97% | 13.82% | 17.56% | 0.32% | |
| EPS (Basic) | -1.96 | -3.04 | -4.13 | -3.65 | -2.88 | -2.27 | |
| EPS (Diluted) | -1.96 | -3.04 | -4.13 | -3.65 | -2.88 | -2.27 | |
| Free Cash Flow | -5.95 | -7.86 | -7.23 | -7.32 | -4.66 | -3.02 | |
| Free Cash Flow Per Share | -1.81 | -2.84 | -2.84 | -2.93 | -2.13 | -1.62 | |
| EBIT | -7 | -8.83 | -10.54 | -9.13 | -6.51 | -4.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.